Literature DB >> 6378359

Prognostic significance of the number of involved areas in the early stages of Hodgkin's disease.

M Tubiana, M Henry-Amar, M Hayat, M Burgers, M Qasim, R Somers, W Sizoo, E Van der Schueren.   

Abstract

An analysis of 1059 patients with clinical stage (CS) I and II Hodgkin's disease was undertaken to determine the prognostic significance of the number of involved sites. In this group of patients the number of involved lymph node areas was highly correlated with the probability of dissemination of occult disease. In the subgroup of patients with involvement of two lymph node sites (CS II2) approximately 50% demonstrated occult dissemination on the other side of the diaphragm as evidenced by subsequent relapse in the untreated subdiaphragmatic region. However, only 15% to 20% of this group had unsuspected disease in regions other than the spleen or the paraaortic lymph nodes. In CS I and II2 supradiaphragmatic patients, who underwent a staging laparotomy, splenic involvement was a powerful prognostic indicator. When the spleen was not involved, less than 10% of patients had disease elsewhere below the diaphragm, whereas, when the spleen was involved as many as 40% of patients had additional subdiaphragmatic sites involved. In the subgroup with three or more lymph node areas involved (CS II3), the proportion of patients with extension of disease on the other side of the diaphragm, as evidenced by later relapse was also about 50%. But in these patients, unlike the CS II2 patients, analysis of relapse patterns showed that occult disease had already disseminated to the pelvic nodes or to extra nodal sites. Furthermore, splenic involvement was of much less prognostic significance because CS II3 patients who did not demonstrate splenic involvement at staging laparotomy had similar relapse incidence and similar relapse patterns as those with positive spleens.

Entities:  

Mesh:

Year:  1984        PMID: 6378359     DOI: 10.1002/1097-0142(19840901)54:5<885::aid-cncr2820540522>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Recognizing unusual manifestations of Hodgkin lymphoma.

Authors:  Nicholas A Barber; Philip J Bierman
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

2.  Chemotherapy of Hodgkin's disease comes of age.

Authors:  J G McVie; R Somers
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

3.  Hodgkin lymphoma, version 2.2015.

Authors:  Richard T Hoppe; Ranjana H Advani; Weiyun Z Ai; Richard F Ambinder; Patricia Aoun; Celeste M Bello; Cecil M Benitez; Philip J Bierman; Kristie A Blum; Robert Chen; Bouthaina Dabaja; Andres Forero; Leo I Gordon; Francisco J Hernandez-Ilizaliturri; Ephraim P Hochberg; Jiayi Huang; Patrick B Johnston; Nadia Khan; David G Maloney; Peter M Mauch; Monika Metzger; Joseph O Moore; David Morgan; Craig H Moskowitz; Carolyn Mulroney; Matthew Poppe; Rachel Rabinovitch; Stuart Seropian; Christina Tsien; Jane N Winter; Joachim Yahalom; Jennifer L Burns; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2015-05       Impact factor: 11.908

4.  Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma.

Authors:  Ying-Jie Zhu; Yue-Li Sun; Yi Xia; Wen-Qi Jiang; Jia-Jia Huang; Hui-Qiang Huang; Tong-Yu Lin; Zhong-Zhen Guan; Zhi-Ming Li
Journal:  Med Oncol       Date:  2011-03-10       Impact factor: 3.064

5.  Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?

Authors:  Pierre Y Salaun; Thomas Gastinne; Caroline Bodet-Milin; Loïc Campion; Pierre Cambefort; Anne Moreau; Steven Le Gouill; Christian Berthou; Philippe Moreau; Françoise Kraeber-Bodéré
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-05       Impact factor: 9.236

6.  Long-term outcomes in patients with early stage nodular lymphocyte-predominant Hodgkin's lymphoma treated with radiotherapy.

Authors:  Abhishek A Solanki; Melissa Horoschak LeMieux; Brian C-H Chiu; Usama Mahmood; Yasmin Hasan; Matthew Koshy
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

7.  Nomograms for predicting the overall and cancer-specific survival of patients with classical Hodgkin lymphoma: a SEER-based study.

Authors:  Yue Zhang; Juan Zhang; Hui Zeng; Xiao-Huan Zhou; He-Bing Zhou
Journal:  Oncotarget       Date:  2017-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.